01061.HK
Essex Bio-Technology Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.21
+3.76%Margins
Gross margin
88.2%
EBITDA margin
24.2%
EBIT margin
19.2%
Net margin
16.7%
FCF margin
11.8%
22.7%
Return on equity
16.0%
Return on assets
22.9%
Return on invested capital
0.97x
Asset turnover
HKD 644.2M
Cash from operations
HKD 1.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026